Abstract:Neurological disease refers to the functional disorders of the central nervous system, peripheral nervous system or plant nervous system caused by a variety of causes such as bacterial infection or genetic. Patients usually show problems such as conscious disorder, sensory disorders, and motor disorder. Common neurological diseases such as Huntington, and Alzheimer's disease, have always been one of the main diseases that endanger human life because of their complex mechanisms and treatment. Gene therapy has always been considered a way to treat diseases. The discovery of Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) has improved gene editing technology and realized the application of various biological fields. CRISPR uses sgRNA to identify target sequences, so that CAS9 protein cuts DNA, and combines the guided RNA with the recognized DNA. Then the nucleic acid-cutting enzyme breaks the DNA dual chain structure, and the host cells were repaired through homologous or non-source mechanisms. CRISPR/Cas9 technology can better perform genetic treatment of neuropathy, making it possible for the development and new treatment methods of human neurodegenerative diseases. This review summarizes the basic principles of CRISPR/Cas9 technology and its application in Huntington's and Alzheimer's disease, as well as discusses the feasibility of CRISPR technology in neurological diseases in the future.

The Application of CRISPR/Cas9 Technology in Neurological Diseases